Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair M. Younossi, Maria Stepanova, Janus P. Ong, et al.
Clinical Gastroenterology and Hepatology (2018) Vol. 17, Iss. 4, pp. 748-755.e3
Open Access | Times Cited: 709

Showing 1-25 of 709 citing articles:

Hepatocellular Carcinoma
Augusto Villanueva
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1450-1462
Closed Access | Times Cited: 3572
Non-alcoholic fatty liver disease – A global public health perspective
Zobair M. Younossi
Journal of Hepatology (2018) Vol. 70, Iss. 3, pp. 531-544
Open Access | Times Cited: 1786
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi, Pegah Golabi, Leyla de Avila, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 4, pp. 793-801
Closed Access | Times Cited: 1748
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik, Hashem B. El‐Serag
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 477-491.e1
Open Access | Times Cited: 1482
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El‐Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1309
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1228
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter, Mary E. Rinella
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1851-1864
Closed Access | Times Cited: 967
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
Amedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, et al.
Hepatology (2019) Vol. 70, Iss. 4, pp. 1457-1469
Open Access | Times Cited: 717
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal, Josep M. Llovet, Mark Yarchoan, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1922-1965
Open Access | Times Cited: 669
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 631
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
James M. Paik, Pegah Golabi, Youssef Younossi, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1605-1616
Closed Access | Times Cited: 623
Epidemiological Features of NAFLD From 1999 to 2018 in China
Jianghua Zhou, Feng Zhou, Wenxin Wang, et al.
Hepatology (2020) Vol. 71, Iss. 5, pp. 1851-1864
Closed Access | Times Cited: 520
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi, Maria Stepanova, Youssef Younossi, et al.
Gut (2019) Vol. 69, Iss. 3, pp. 564-568
Closed Access | Times Cited: 451
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 437
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
Zobair M. Younossi, Maria Stepanova, Janus P. Ong, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 580-589.e5
Open Access | Times Cited: 415
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Fasiha Kanwal, Amit G. Singal
Gastroenterology (2019) Vol. 157, Iss. 1, pp. 54-64
Open Access | Times Cited: 394
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Daniel Q. Huang, Amit G. Singal, Yuko Kono, et al.
Cell Metabolism (2022) Vol. 34, Iss. 7, pp. 969-977.e2
Open Access | Times Cited: 328
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison, Stephen A. Harrison, Gad Cotter, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1322-1332
Closed Access | Times Cited: 314
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
Rohit Loomba, Joseph K. Lim, Heather Patton, et al.
Gastroenterology (2020) Vol. 158, Iss. 6, pp. 1822-1830
Open Access | Times Cited: 293
Disease Burden of Hepatocellular Carcinoma: A Global Perspective
Mehmet Sayıner, Pegah Golabi, Zobair M. Younossi
Digestive Diseases and Sciences (2019) Vol. 64, Iss. 4, pp. 910-917
Closed Access | Times Cited: 287
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 284
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
Debashis Haldar, Barbara Kern, James Hodson, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 2, pp. 313-322
Open Access | Times Cited: 270
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 267
Epidemiology and risk-stratification of NAFLD-associated HCC
George N. Ioannou
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1476-1484
Open Access | Times Cited: 253
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi, Mazen Noureddin, Naim Alkhouri, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 373-392
Closed Access | Times Cited: 231
Page 1 - Next Page

Scroll to top